Guidance Document: Drug Submissions Relying on Third-Party Data (Literature and Market Experience) (English, HTML)

View metadata and access the original English HTML file: Guidance Document: Drug Submissions Relying on Third-Party Data (Literature and Market Experience).

Format

HTML

Access

file-only

Publisher-reported update

2023-09-01

The objective of this document is to ensure that sponsors of SRTDs have the necessary information to satisfy the regulatory requirements under the Food and Drug Regulations with respect to safety, efficacy and quality which provides the basis of Health Canada's drug review and approval process.

Access original file